In patients with CHD, a Mediterranean vs. low-fat diet reduced major CV events at 7 y

Harvey J Murff1

  • 1Vanderbilt University Medical Center, Nashville, Tennessee, USA (H.J.M.).

Annals of Internal Medicine
|September 5, 2022
PubMed

Insights

The Mediterranean diet, rich in olive oil and nuts, significantly reduced cardiovascular events compared to a low-fat diet in long-term secondary prevention. This dietary approach is crucial for heart health.

Area of Science:

  • Cardiovascular Medicine
  • Nutritional Science
  • Preventive Cardiology

Background:

  • Cardiovascular diseases (CVD) remain a leading cause of mortality worldwide.
  • Secondary prevention strategies are vital to reduce recurrent cardiovascular events.
  • Dietary interventions show promise in managing CVD risk factors.

Purpose of the Study:

  • To compare the long-term efficacy of a Mediterranean diet versus a low-fat diet for secondary cardiovascular prevention.
  • To assess the impact of these diets on major cardiovascular events and mortality.

Main Methods:

  • The study was a randomized controlled trial (CORDIOPREV).
  • Participants with established cardiovascular disease were assigned to either a Mediterranean diet or a low-fat diet.
  • Long-term follow-up was conducted to record cardiovascular events.

Main Results:

  • The Mediterranean diet group experienced a significant reduction in major cardiovascular events compared to the low-fat diet group.
  • Specific benefits included fewer strokes and overall cardiovascular mortality in the Mediterranean diet group.
  • Adherence to the Mediterranean diet was associated with improved lipid profiles and reduced inflammation.

Conclusions:

  • A long-term Mediterranean diet intervention is highly effective for secondary cardiovascular disease prevention.
  • This dietary pattern offers significant benefits over a conventional low-fat diet for patients with existing heart conditions.
  • Promoting the Mediterranean diet is a key strategy in public health for cardiovascular risk reduction.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
25
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
837
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
26
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.1K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
25